BGB-B3227-101
Terminated
A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
BeOne Study ID
ClinicalTrials.gov ID
EudraCT or EUCT Number
China Drug Trials ID
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents